Export Ready — 

Pharmaceuticals biodegradation by activated sludge and pure cultures

Bibliographic Details
Main Author: Bessa, Vânia S.
Publication Date: 2013
Other Authors: Moreira, Irina S., Maia, Alexandra S., Tiritan, Maria E., Castro, Paula M. L.
Language: eng
Source: Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
Download full: http://hdl.handle.net/10400.14/13446
Summary: The occurrence of pharmaceuticals in the environment have been a topic of increasing concern. Most of the pharmaceuticals are not completely mineralized in the human body and are released on the sewage systems as the pharmaceutical itself and as their “biologically active” metabolites through excretion, as well as by improper elimination and disposal. Once current wastewater treatment plants (WWTPs) are not designed to remove these emerging pollutant, they are easily released into the environment.The effects of halogen on biological properties of molecules have had a marked impact on various fields such as pharmacology. It can improve metabolic stability, bioavailability and interactions with the biological target. However, it also increases the recalcitrance of the molecule to biotic and abiotic degradation. Ciprofloxacin (CPF) and Diclofenac (DCF) are two widely used halogenated pharmaceuticals, commonly found in the environment in concentrations that can range ng L−1 to mg L−1. CPF is a common human and veterinary broad-spectrum fluoroquinolone antibiotic. DCF is a non-steroidal anti-inflammatory drug (NSAID), also used as analgesic and antithermic treatment. In the present study, biodegradation of CPF and DCF was assessed by selective enrichements with actived sludge and with pure cultures of three different strains - Labrys portucalensis (F11) and two Rhodococcus spp. (FP1 and S2) – which had previously demonstrated capacity to degrade a range of halogenated compounds. For CPF selective enrichments, a degradation of 100% was achived after 206 days, although without fluoride release. These findings indicate that these selective enrichments are good candidates to find a bacterial strain able to biodegrade CPF. Regarding the pure cultures, F11 exhibited the highest degradation capacity (57%) after 62 days, but also without fluoride release. Concerning DCF selective enrichments, it was released 68% of the stoichiometrically expected cloride ion behind 131 days. In the experiments with pure cultures, F11 and S2, was released the totality of the stoichiometrically expected cloride, elapsed 131 days. These results indicate that these two strains are promising for DCF biodegradation.
id RCAP_e6dd2a6d576f9c1581e541f2ce89faf4
oai_identifier_str oai:repositorio.ucp.pt:10400.14/13446
network_acronym_str RCAP
network_name_str Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
repository_id_str https://opendoar.ac.uk/repository/7160
spelling Pharmaceuticals biodegradation by activated sludge and pure culturesPharmaceuticalsEnvironmentBiodegradationCiprofloxacinDiclofenacThe occurrence of pharmaceuticals in the environment have been a topic of increasing concern. Most of the pharmaceuticals are not completely mineralized in the human body and are released on the sewage systems as the pharmaceutical itself and as their “biologically active” metabolites through excretion, as well as by improper elimination and disposal. Once current wastewater treatment plants (WWTPs) are not designed to remove these emerging pollutant, they are easily released into the environment.The effects of halogen on biological properties of molecules have had a marked impact on various fields such as pharmacology. It can improve metabolic stability, bioavailability and interactions with the biological target. However, it also increases the recalcitrance of the molecule to biotic and abiotic degradation. Ciprofloxacin (CPF) and Diclofenac (DCF) are two widely used halogenated pharmaceuticals, commonly found in the environment in concentrations that can range ng L−1 to mg L−1. CPF is a common human and veterinary broad-spectrum fluoroquinolone antibiotic. DCF is a non-steroidal anti-inflammatory drug (NSAID), also used as analgesic and antithermic treatment. In the present study, biodegradation of CPF and DCF was assessed by selective enrichements with actived sludge and with pure cultures of three different strains - Labrys portucalensis (F11) and two Rhodococcus spp. (FP1 and S2) – which had previously demonstrated capacity to degrade a range of halogenated compounds. For CPF selective enrichments, a degradation of 100% was achived after 206 days, although without fluoride release. These findings indicate that these selective enrichments are good candidates to find a bacterial strain able to biodegrade CPF. Regarding the pure cultures, F11 exhibited the highest degradation capacity (57%) after 62 days, but also without fluoride release. Concerning DCF selective enrichments, it was released 68% of the stoichiometrically expected cloride ion behind 131 days. In the experiments with pure cultures, F11 and S2, was released the totality of the stoichiometrically expected cloride, elapsed 131 days. These results indicate that these two strains are promising for DCF biodegradation.VeritatiBessa, Vânia S.Moreira, Irina S.Maia, Alexandra S.Tiritan, Maria E.Castro, Paula M. L.2013-12-16T12:13:55Z20132013-01-01T00:00:00Zconference objectinfo:eu-repo/semantics/publishedVersionapplication/pdfhttp://hdl.handle.net/10400.14/13446enginfo:eu-repo/semantics/openAccessreponame:Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)instname:FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologiainstacron:RCAAP2025-03-13T13:43:18Zoai:repositorio.ucp.pt:10400.14/13446Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireinfo@rcaap.ptopendoar:https://opendoar.ac.uk/repository/71602025-05-29T01:59:12.796769Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) - FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologiafalse
dc.title.none.fl_str_mv Pharmaceuticals biodegradation by activated sludge and pure cultures
title Pharmaceuticals biodegradation by activated sludge and pure cultures
spellingShingle Pharmaceuticals biodegradation by activated sludge and pure cultures
Bessa, Vânia S.
Pharmaceuticals
Environment
Biodegradation
Ciprofloxacin
Diclofenac
title_short Pharmaceuticals biodegradation by activated sludge and pure cultures
title_full Pharmaceuticals biodegradation by activated sludge and pure cultures
title_fullStr Pharmaceuticals biodegradation by activated sludge and pure cultures
title_full_unstemmed Pharmaceuticals biodegradation by activated sludge and pure cultures
title_sort Pharmaceuticals biodegradation by activated sludge and pure cultures
author Bessa, Vânia S.
author_facet Bessa, Vânia S.
Moreira, Irina S.
Maia, Alexandra S.
Tiritan, Maria E.
Castro, Paula M. L.
author_role author
author2 Moreira, Irina S.
Maia, Alexandra S.
Tiritan, Maria E.
Castro, Paula M. L.
author2_role author
author
author
author
dc.contributor.none.fl_str_mv Veritati
dc.contributor.author.fl_str_mv Bessa, Vânia S.
Moreira, Irina S.
Maia, Alexandra S.
Tiritan, Maria E.
Castro, Paula M. L.
dc.subject.por.fl_str_mv Pharmaceuticals
Environment
Biodegradation
Ciprofloxacin
Diclofenac
topic Pharmaceuticals
Environment
Biodegradation
Ciprofloxacin
Diclofenac
description The occurrence of pharmaceuticals in the environment have been a topic of increasing concern. Most of the pharmaceuticals are not completely mineralized in the human body and are released on the sewage systems as the pharmaceutical itself and as their “biologically active” metabolites through excretion, as well as by improper elimination and disposal. Once current wastewater treatment plants (WWTPs) are not designed to remove these emerging pollutant, they are easily released into the environment.The effects of halogen on biological properties of molecules have had a marked impact on various fields such as pharmacology. It can improve metabolic stability, bioavailability and interactions with the biological target. However, it also increases the recalcitrance of the molecule to biotic and abiotic degradation. Ciprofloxacin (CPF) and Diclofenac (DCF) are two widely used halogenated pharmaceuticals, commonly found in the environment in concentrations that can range ng L−1 to mg L−1. CPF is a common human and veterinary broad-spectrum fluoroquinolone antibiotic. DCF is a non-steroidal anti-inflammatory drug (NSAID), also used as analgesic and antithermic treatment. In the present study, biodegradation of CPF and DCF was assessed by selective enrichements with actived sludge and with pure cultures of three different strains - Labrys portucalensis (F11) and two Rhodococcus spp. (FP1 and S2) – which had previously demonstrated capacity to degrade a range of halogenated compounds. For CPF selective enrichments, a degradation of 100% was achived after 206 days, although without fluoride release. These findings indicate that these selective enrichments are good candidates to find a bacterial strain able to biodegrade CPF. Regarding the pure cultures, F11 exhibited the highest degradation capacity (57%) after 62 days, but also without fluoride release. Concerning DCF selective enrichments, it was released 68% of the stoichiometrically expected cloride ion behind 131 days. In the experiments with pure cultures, F11 and S2, was released the totality of the stoichiometrically expected cloride, elapsed 131 days. These results indicate that these two strains are promising for DCF biodegradation.
publishDate 2013
dc.date.none.fl_str_mv 2013-12-16T12:13:55Z
2013
2013-01-01T00:00:00Z
dc.type.driver.fl_str_mv conference object
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10400.14/13446
url http://hdl.handle.net/10400.14/13446
dc.language.iso.fl_str_mv eng
language eng
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.source.none.fl_str_mv reponame:Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
instname:FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
instacron:RCAAP
instname_str FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
instacron_str RCAAP
institution RCAAP
reponame_str Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
collection Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
repository.name.fl_str_mv Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) - FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
repository.mail.fl_str_mv info@rcaap.pt
_version_ 1833601190600900609